Announcements Trials
Browse Landscape

Phase

Phase NA 22Phase 3 3Phase 2/3 3Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 15Recruiting 6Withdrawn 3Unknown 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 285Prostatic Neoplasms 208Neoplasms 202Neoplasm Metastasis 179Melanoma 164Multiple Myeloma 158Colorectal Neoplasms 157Leukemia, Myeloid, Acute 143Lung Neoplasms 132Leukemia 126Lymphoma 118Pancreatic Neoplasms 117Recurrence 111Ovarian Neoplasms 111Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Non-Hodgkin 104Carcinoma, Renal Cell 104Brain Neoplasms 89Myelodysplastic Syndromes 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Glioblastoma 84Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Follicular 79Carcinoma, Hepatocellular 79Head and Neck Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Urinary Bladder Neoplasms 66Stomach Neoplasms 61Hodgkin Disease 59

Interventions

SLI381 1Methylphenidate 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Depression × Clear all
NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Mayo Clinic

Phase 2 Terminated
5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

NCT00069927 2014-02-03

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

University of South Florida

Phase 2 Terminated
12 enrolled

Depression, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡